Pediatric Epilepsy Therapeutics

Pediatric Epilepsy Therapeutics

Global Pediatric Epilepsy Therapeutics Market to Reach US$14.7 Billion by 2030

The global market for Pediatric Epilepsy Therapeutics estimated at US$11.7 Billion in the year 2023, is expected to reach US$14.7 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. Third Generation Drugs, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$7.0 Billion by the end of the analysis period. Growth in the Second Generation Drugs segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.2 Billion While China is Forecast to Grow at 6.5% CAGR

The Pediatric Epilepsy Therapeutics market in the U.S. is estimated at US$3.2 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.0 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Pediatric Epilepsy Therapeutics Market - Key Trends and Drivers Summarized

Pediatric epilepsy is a neurological disorder characterized by recurrent seizures in children, significantly impacting their development and quality of life. Effective management of pediatric epilepsy involves a multidisciplinary approach, including pharmacological treatments, lifestyle modifications, and sometimes surgical interventions. The primary goal of pediatric epilepsy therapeutics is to achieve seizure control with minimal side effects, thereby allowing normal cognitive and physical development. Antiepileptic drugs (AEDs) are the cornerstone of treatment, with options such as valproate, levetiracetam, and lamotrigine being commonly prescribed. These medications work by stabilizing neural activity and preventing the abnormal electrical discharges that cause seizures. Treatment regimens are often tailored to the individual, taking into account the type of epilepsy, the child’s age, and any co-existing conditions.

Recent advancements in pediatric epilepsy therapeutics have focused on improving the efficacy and safety profile of existing medications while also developing novel treatment options. Innovations such as extended-release formulations and new drug delivery systems aim to enhance patient compliance by reducing the frequency of dosing and minimizing side effects. Additionally, research into the genetic underpinnings of epilepsy has led to the development of targeted therapies that address specific genetic mutations associated with the disorder. This precision medicine approach not only improves treatment outcomes but also reduces the trial-and-error period often associated with finding the right medication. Non-pharmacological treatments, such as ketogenic diets and neurostimulation devices, are also gaining traction as complementary therapies, providing additional avenues for managing refractory epilepsy cases where traditional medications fall short.

The growth in the pediatric epilepsy therapeutics market is driven by several factors, including technological advancements, increased awareness and diagnosis of epilepsy, and the rising prevalence of the disorder. Technological innovations, such as the development of wearable seizure detection devices and advanced neuroimaging techniques, are enabling earlier and more accurate diagnosis, which in turn drives demand for effective treatments. The growing understanding of epilepsy’s genetic basis is also propelling the market, as it opens up new possibilities for targeted therapies. Moreover, the increasing availability of healthcare services and improved access to medical care in emerging markets are expanding the addressable market for pediatric epilepsy treatments. Regulatory support for orphan drugs and pediatric-specific formulations is further accelerating the development and approval of new therapies. As these trends continue, the pediatric epilepsy therapeutics market is poised for sustained growth, offering improved treatment options and better outcomes for affected children and their families.

Select Competitors (Total 86 Featured) -
  • Azurity Pharmaceuticals, Inc.
  • Biogen, Inc.
  • Bio-Pharm Solutions Company Limited
  • Eisai Co., Ltd.
  • EpyGenix Therapeutics
  • GSK Plc
  • Jazz Pharmaceuticals Plc
  • Marinus Pharmaceuticals, Inc.
  • Neurelis, Inc.
  • Neurocrine Biosciences, Inc.
  • Praxis Precision Medicines
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co., Ltd.
  • UCB SA
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Pediatric Epilepsy Therapeutics - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Technological Innovations Propel Growth in Pediatric Epilepsy Therapeutics Market
Rising Prevalence of Pediatric Epilepsy Expands Addressable Market Opportunity
Increased Awareness and Early Diagnosis Drives Demand for Effective Treatments
Advances in Genetic Research Strengthen Business Case for Targeted Therapies
Development of Wearable Seizure Detection Devices Spurs Market Growth
Growing Adoption of Precision Medicine Approaches Drives Adoption of New Therapies
Non-Pharmacological Treatments Gain Traction as Complementary Therapies
Improved Access to Healthcare Services in Emerging Markets Expands Market Reach
Increasing Investment in Pediatric Neurology Research Generates New Opportunities
Enhanced Neuroimaging Techniques Accelerate Accurate Diagnosis and Treatment Planning
Rising Healthcare Expenditure Supports Sustained Market Growth
Evolution of Personalized Treatment Plans Improves Patient Outcomes
Increased Focus on Minimizing Side Effects Drives Development of Safer Medications
Expansion of Telemedicine Services Creates New Opportunities for Pediatric Epilepsy Care
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Pediatric Epilepsy Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Pediatric Epilepsy Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Pediatric Epilepsy Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Third Generation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Third Generation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Third Generation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Second Generation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Second Generation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Second Generation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for First Generation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for First Generation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for First Generation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Pediatric Epilepsy Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 14: USA Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 15: USA Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: USA 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
CANADA
TABLE 17: Canada Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 18: Canada Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: Canada 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
JAPAN
Pediatric Epilepsy Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 20: Japan Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 21: Japan Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: Japan 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
CHINA
Pediatric Epilepsy Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 23: China Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 24: China Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: China 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
EUROPE
Pediatric Epilepsy Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 26: Europe Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: Europe Historic Review for Pediatric Epilepsy Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: Europe 16-Year Perspective for Pediatric Epilepsy Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 29: Europe Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: Europe Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: Europe 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
FRANCE
Pediatric Epilepsy Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 32: France Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: France Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: France 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
GERMANY
Pediatric Epilepsy Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 35: Germany Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: Germany Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: Germany 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
ITALY
TABLE 38: Italy Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: Italy Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: Italy 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
UNITED KINGDOM
Pediatric Epilepsy Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 41: UK Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: UK Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: UK 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
SPAIN
TABLE 44: Spain Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Spain Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Spain 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
RUSSIA
TABLE 47: Russia Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Russia Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Russia 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Rest of Europe Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Rest of Europe 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Pediatric Epilepsy Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 54: Asia-Pacific Historic Review for Pediatric Epilepsy Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Asia-Pacific 16-Year Perspective for Pediatric Epilepsy Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Asia-Pacific Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Asia-Pacific 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
AUSTRALIA
Pediatric Epilepsy Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 59: Australia Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Australia Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Australia 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
INDIA
Pediatric Epilepsy Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 62: India Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: India Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: India 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 65: South Korea Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: South Korea Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: South Korea 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Rest of Asia-Pacific Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
LATIN AMERICA
Pediatric Epilepsy Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 71: Latin America Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 72: Latin America Historic Review for Pediatric Epilepsy Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Latin America 16-Year Perspective for Pediatric Epilepsy Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 74: Latin America Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Latin America Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Latin America 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 77: Argentina Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Argentina Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Argentina 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
BRAZIL
TABLE 80: Brazil Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Brazil Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Brazil 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
MEXICO
TABLE 83: Mexico Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Mexico Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Mexico 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Rest of Latin America Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Rest of Latin America 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
MIDDLE EAST
Pediatric Epilepsy Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 89: Middle East Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 90: Middle East Historic Review for Pediatric Epilepsy Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Middle East 16-Year Perspective for Pediatric Epilepsy Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 92: Middle East Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Middle East Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Middle East 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
IRAN
TABLE 95: Iran Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Iran Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Iran 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
ISRAEL
TABLE 98: Israel Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Israel Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Israel 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Saudi Arabia Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Saudi Arabia 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 104: UAE Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: UAE Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: UAE 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Rest of Middle East Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Rest of Middle East 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
AFRICA
Pediatric Epilepsy Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 110: Africa Recent Past, Current & Future Analysis for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Africa Historic Review for Pediatric Epilepsy Therapeutics by Product Type - Third Generation, Second Generation and First Generation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Africa 16-Year Perspective for Pediatric Epilepsy Therapeutics by Product Type - Percentage Breakdown of Value Sales for Third Generation, Second Generation and First Generation for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings